Uninterrupted administration of edoxaban vs vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation: Rationale and design of the ELIMINATE‐AF study.

Patients with atrial fibrillation (AF) are at an approximately 0.5% to 3% increased risk of thromboembolism during and immediately after catheter ablation. Treatment guidelines recommend periprocedural oral anticoagulation plus unfractionated heparin during ablation. Rivaroxaban and dabigatran are t...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Cardiol
Glavni autori: Hohnloser, Stefan H., Camm, John, Cappato, Riccardo, Diener, Hans‐Christoph, Heidbuchel, Hein, Lanz, Hans‐Joachim, Mont, Lluís, Morillo, Carlos A., Smolnik, Rüdiger, Yin, Ophelia Q.P., Kautzner, Josef
Format: Artigo
Jezik:Inglês
Izdano: Wiley Periodicals, Inc. 2018
Teme:
Trial Designs
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6489708/
https://ncbi.nlm.nih.gov/pubmed/29663464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22918
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items